Friday, October 30, 2020

The e-doctor will see you now

The term ‘doctor in a box’ – once used as a derisive term for physicians that provide primary health care at an hourly rate in unaffiliated ambulatory care clinics – has taken on a very different meaning. There, for the past seven years, it has been used to describe several formats of telemedicine...

FDA issues surprise rejection of Gilead, Galapagos rheumatoid arthritis drug

Buildings 1 and 2 of the FDA campus A drug for rheumatoid arthritis that was seen as potentially a significant driver of growth has been turned down by the Food and Drug Administration, dealing a blow to the companies that developed it. Foster City, California-based Gilead Sciences said in an after-hours announcement Tuesday that...

3 technologies that will play a pivotal role in the pandemic and beyond

Decentralized clinical trial design
Digital health technology is playing a critical role in the Covid-19 public health crisis by helping support patient-provider connection across the care continuum. Since the pandemic started back in March, clinicians have seen many patients with potential symptoms looking for care. It’s an uncertain and scary time, especially for those who are at...

Why hydroxychloroquine’s appeal endures despite evidence it doesn’t work for Covid-19

“Any study that says hydroxychloroquine doesn’t work is fake science.” Those were the words of Dr. Stella Immanuel, a physician who claimed to have successfully treated 350 Covid-19 patients with hydroxychloroquine, azithromycin and zinc. Immanuel appeared with a Tea Party-linked group calling itself America’s Frontline Doctors in a July 27 video of a press...

Report: FDA halted move to authorize convalescent plasma for Covid-19 over evidence concerns

Among the various treatments proposed for Covid-19, one of the most closely watched consists of plasma donated by patients who have survived the disease, which is rich in antibodies against the SARS-CoV-2 virus. But according to a news report, the Food and Drug Administration stopped short of issuing an emergency use authorization for...

Grand Rounds raises $175M – MedCity News

Fast-growing care coordination startup Grand Rounds has sold several large companies on its healthcare assistant program, which helps employees navigate their benefits and find in-network providers. The startup says it works with more than 130 large, self-insured companies, including retailers like Walmart and The Home Depot. Now, with $175 million in new funding, Grand...

Fitbit takes on Apple with new smartwatch

In its newest competitor to the Apple Watch, Fitbit rolled out a $330 smartwatch with a few new tricks. The company’s Fitbit Sense smartwatch has new sensors to track stress levels and skin temperature, as well as a new ECG app that is pending FDA clearance. Fitbit has emphasized health features in its devices...

You Can Now Save Your Apple Watch Workouts To Strava Directly

The Apple Watch is the most popular wearable in the world, and that’s in no small way because of its sports and activity tracking features. Strava, for its part, is one of the most popular activity sharing apps in the world. Considering those two facts, it’s been more than a little annoying...

Amwell files for IPO, strikes partnership with Google

Boston-based telehealth company Amwell plans to go public, including a $100 million investment from Google.  The company filed preliminary paperwork with the Securities and Exchange Commission to be listed on the New York Stock Exchange under the symbol AMWL. Amwell plans to raise $100 million in the offering — likely a placeholder number, as...

Portable dialysis company Outset Medical files for IPO

Outset Medical, a company making portable dialysis systems, filed preliminary paperwork for an IPO on Friday. The San Jose-based company hasn’t yet set a price range for its stock, but it said it plans to raise $100 million — a commonly used placeholder figure. Most of Outset’s business comes from the use of its...
0FansLike
0FollowersFollow
- Advertisement -

Must Read